Bank Central Asia BBCA IJ - Buy - Solid YTD Jul-24 results
BBCA’s bank-only Jul-24 earnings of IDR4.9tr (+1% m-m / +17% y-y) brings YTD Jul-24 headline profit to
Despite the persistent challenging macroeconomic backdrops, as we head into 2025F, we believe major Indonesia banks could improve their earnings profile. We think the overall liquidity in the banking system is likely to remain tight, as shown in Fig. 1, whereby LDRs for KBMI 4 and 3 banks (i.e., large and mid-large banks – predominantly the top 10 largest domestic banks) can be seen hovering above the system average of ~88%. That said, tight liquidity does not appear to worsen. We think many smaller-sized banks have not competed as aggressively as in the past two to three years. Consequently, we expect major banks could broadly retain their high quality loan growth.
In Fig 2, we provide outlooks for loan growth at the major banks respectively based on our recent discussions with these banks. Both BMRI and BBCA appear to have projected lower loan growth in 2025 than 2024’s. These are expected owing to their respective YTD October 2024 y-y loan growth were above system-wides. Most notably, BBCA is expecting much lower loan growth in 2025 than it had in 2024, to the extent that its projected growth would be inferior to projected system growth (from BI).
Despite more prudent loan growth, based on our assumptions, we believe earnings risks for these banks would be muted. This is based on our expectations that their NIMs for 2025F are likely to be more stable than in 2024’s (i.e., with more stable NIMs, banks need not drive loan growth to compensate for lower NIMs). Overall, this is likely to result in improved earnings profiles for these banks (excluding BBRI, which may still require more write-offs at its mass market segment). This would also indicate that banks can afford to have stable credit costs (CoC) in 2025F (unlike in 2024, where some banks relied on lower CoC to drive profit growth). Thus, lower loan-loss-provision ratios (LLRs) for these banks would be stable, which could minimize future earnings risks.
Considering the above, we reiterate our long-term overweight view on major Indonesia banks. Within these major banks, we view BBCA as the most resilient.
Valuations and risks
BBCA — We derive our TP of IDR13,200 using a DuPont analysis with the following key parameters: a risk-free rate of 6.5%, an equity risk premium of 7.8%, beta of 0.8x and a CAR-adjusted ROAE of 24.5% (all unchanged). Our TP implies 5.4x FY25F P/B (BVPS of IDR2,468 (vs current price valuation of 4.2x) and 26.9x FY25F P/E (EPS of IDR 493.4 (vs current price valuation of 21.0x). Key downside risks include worsening economic trends, tighter liquidity competition, and/or higher credit cost and opex growth. We maintain our Buy rating and TP of IDR13,200.
BMRI — We derive our TP of IDR8,450 using DuPont methodology. Key parameters include a risk-free rate of 6.5%, an equity risk premium of 7.8%, a CAR-adjusted ROAE of 19.8% and beta of 1.03x (all unchanged). We also use 2025F book value as reference. Our TP implies a 2.5x FY25F P/B (BVPS of IDR3,432) and a 12.4x FY25F P/E (EPS of IDR696) – compared to current price valuations of 2.1x and a 10.6x, respectively. Key downside risks are worse-than-expected macroeconomic trends, government intervention, tight liquidity competition, and higher credit cost and opex growth. We maintain our Buy rating and TP of IDR,8450.
BBRI — We derive our TP of IDR6,300 using a DuPont analysis with a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 10.0%, beta 0.8x, and a CAR-adjusted ROAE of 18.0% (all unchanged). We also use 2025F book value as a reference. The implied multiples at our TP would be 2.9x 2025F BVPS of IDR2,255 and 14.8x 2025F earnings of IDR428 (compared to current multiples of 2.1x and 11.1x, respectively). Key downside risks to our view are worsening of macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition, which could increase funding costs, worsening credit quality, which would raise credit costs, and higher opex. We maintain our Buy rating and TP of IDR6,300.
BBNI — We derive our TP of IDR6,600 based on a DuPont analysis, assuming a risk-free rate of 6.5%, an equity risk premium of 7.8%, growth of 8.5%, beta 1.0x and a CAR-adjusted ROAE of 16.5% (all unchanged). We also use 2025F book as a reference. The implied multiples at our TP are 1.4x 2025F BVPS of IDR4,712 and 10.7x 2025F earnings of IDR612.8 (compared to current multiples of 1.2x and 9.3x, respectively). Key downside risks to our view are worsening macroeconomic trends, unfavorable regulatory changes, and tighter liquidity competition (which would increase funding cost), and worsening credit quality (which would raise credit costs), and higher opex. We maintain our Buy rating and TP of IDR6,600.
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.